Brain stim indicated as a monotherapy or adjunctive treatment for major depressive disorde ...

WEST VIRGINIA (WVNS) – Millions of Americans living with major depressive disorder struggle to find treatment options that ...

EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availability EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving ...

Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...

Overall, Contreras underscored that combining predictive analytics, AI-driven modeling, and digital monitoring can help ...

Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...

Zachary Contreras highlighted strategies discussed at AMCP Nexus for improving timely access to monoclonal migraine receptor ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

Results of a new study show that patients with major depressive order who have not been helped by antidepressants could benefit from nitrous oxide.

Please provide your email address to receive an email when new articles are posted on . At day 43, lumateperone led to greater improvement vs. placebo on all metrics. Treatment-emergent adverse events ...

As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...

Rates of depression notably spiked during the pandemic. But even though life has largely returned to normal, we’re still in a mental health crisis. In 2023, the U.S. Surgeon General declared an ...